174 related articles for article (PubMed ID: 9398050)
1. Topoisomerase-I inhibitors for human malignant glioma: differential modulation of p53, p21, bax and bcl-2 expression and of CD95-mediated apoptosis by camptothecin and beta-lapachone.
Weller M; Winter S; Schmidt C; Esser P; Fontana A; Dichgans J; Groscurth P
Int J Cancer; 1997 Nov; 73(5):707-14. PubMed ID: 9398050
[TBL] [Abstract][Full Text] [Related]
2. Induction of apoptosis in MCF-7:WS8 breast cancer cells by beta-lapachone.
Wuerzberger SM; Pink JJ; Planchon SM; Byers KL; Bornmann WG; Boothman DA
Cancer Res; 1998 May; 58(9):1876-85. PubMed ID: 9581828
[TBL] [Abstract][Full Text] [Related]
3. Boswellic acids and malignant glioma: induction of apoptosis but no modulation of drug sensitivity.
Glaser T; Winter S; Groscurth P; Safayhi H; Sailer ER; Ammon HP; Schabet M; Weller M
Br J Cancer; 1999 May; 80(5-6):756-65. PubMed ID: 10360653
[TBL] [Abstract][Full Text] [Related]
4. Potentiation of CD95L-induced apoptosis of human malignant glioma cells by topotecan involves inhibition of RNA synthesis but not changes in CD95 or CD95L protein expression.
Winter S; Weller M
J Pharmacol Exp Ther; 1998 Sep; 286(3):1374-82. PubMed ID: 9732400
[TBL] [Abstract][Full Text] [Related]
5. Taxol-mediated augmentation of CD95 ligand-induced apoptosis of human malignant glioma cells: association with bcl-2 phosphorylation but neither activation of p53 nor G2/M cell cycle arrest.
Roth W; Wagenknecht B; Grimmel C; Dichgans J; Weller M
Br J Cancer; 1998; 77(3):404-11. PubMed ID: 9472635
[TBL] [Abstract][Full Text] [Related]
6. Dexamethasone-mediated protection from drug cytotoxicity: association with p21WAF1/CIP1 protein accumulation?
Naumann U; Durka S; Weller M
Oncogene; 1998 Sep; 17(12):1567-75. PubMed ID: 9794234
[TBL] [Abstract][Full Text] [Related]
7. The topoisomerase II inhibitor, genistein, induces G2/M arrest and apoptosis in human malignant glioma cell lines.
Schmidt F; Knobbe CB; Frank B; Wolburg H; Weller M
Oncol Rep; 2008 Apr; 19(4):1061-6. PubMed ID: 18357397
[TBL] [Abstract][Full Text] [Related]
8. beta-lapachone induces cell cycle arrest and apoptosis in human colon cancer cells.
Huang L; Pardee AB
Mol Med; 1999 Nov; 5(11):711-20. PubMed ID: 10656873
[TBL] [Abstract][Full Text] [Related]
9. The topoisomerase I inhibitors, camptothecin and beta-lapachone, induce apoptosis of human retinal pigment epithelial cells.
Hueber A; Esser P; Heimann K; Kociok N; Winter S; Weller M
Exp Eye Res; 1998 Nov; 67(5):525-30. PubMed ID: 9878214
[TBL] [Abstract][Full Text] [Related]
10. Immunochemotherapy of malignant glioma: synergistic activity of CD95 ligand and chemotherapeutics.
Roth W; Fontana A; Trepel M; Reed JC; Dichgans J; Weller M
Cancer Immunol Immunother; 1997 Mar; 44(1):55-63. PubMed ID: 9111585
[TBL] [Abstract][Full Text] [Related]
11. Antisense Bcl-xl down-regulation switches the response to topoisomerase I inhibition from senescence to apoptosis in colorectal cancer cells, enhancing global cytotoxicity.
Hayward RL; Macpherson JS; Cummings J; Monia BP; Smyth JF; Jodrell DI
Clin Cancer Res; 2003 Jul; 9(7):2856-65. PubMed ID: 12855666
[TBL] [Abstract][Full Text] [Related]
12. Induction of apoptosis in human retinoblastoma cells by topoisomerase inhibitors.
Giuliano M; Lauricella M; Vassallo E; Carabillò M; Vento R; Tesoriere G
Invest Ophthalmol Vis Sci; 1998 Jul; 39(8):1300-11. PubMed ID: 9660477
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of p53, induction of Bax and activation of caspases during beta-lapachone-mediated apoptosis in human prostate epithelial cells.
Choi YH; Kim MJ; Lee SY; Lee YN; Chi GY; Eom HS; Kim ND; Choi BT
Int J Oncol; 2002 Dec; 21(6):1293-9. PubMed ID: 12429980
[TBL] [Abstract][Full Text] [Related]
14. Beta-lapachone-mediated apoptosis in human promyelocytic leukemia (HL-60) and human prostate cancer cells: a p53-independent response.
Planchon SM; Wuerzberger S; Frydman B; Witiak DT; Hutson P; Church DR; Wilding G; Boothman DA
Cancer Res; 1995 Sep; 55(17):3706-11. PubMed ID: 7641180
[TBL] [Abstract][Full Text] [Related]
15. Betulinic acid-induced apoptosis in glioma cells: A sequential requirement for new protein synthesis, formation of reactive oxygen species, and caspase processing.
Wick W; Grimmel C; Wagenknecht B; Dichgans J; Weller M
J Pharmacol Exp Ther; 1999 Jun; 289(3):1306-12. PubMed ID: 10336521
[TBL] [Abstract][Full Text] [Related]
16. p53 enhances BAK and CD95 expression in human malignant glioma cells but does not enhance CD95L-induced apoptosis.
Pohl U; Wagenknecht B; Naumann U; Weller M
Cell Physiol Biochem; 1999; 9(1):29-37. PubMed ID: 10352342
[TBL] [Abstract][Full Text] [Related]
17. Induction of apoptosis by beta-lapachone in human prostate cancer cells.
Li CJ; Wang C; Pardee AB
Cancer Res; 1995 Sep; 55(17):3712-5. PubMed ID: 7641181
[TBL] [Abstract][Full Text] [Related]
18. Hypericin-induced apoptosis of human malignant glioma cells is light-dependent, independent of bcl-2 expression, and does not require wild-type p53.
Weller M; Trepel M; Grimmel C; Schabet M; Bremen D; Krajewski S; Reed JC
Neurol Res; 1997 Oct; 19(5):459-70. PubMed ID: 9329022
[TBL] [Abstract][Full Text] [Related]
19. Differences in induction of p53, p21WAF1 and apoptosis in relation to cell cycle phase of MCF-7 cells treated with camptothecin.
Deptala A; Li X; Bedner E; Cheng W; Traganos F; Darzynkiewicz Z
Int J Oncol; 1999 Nov; 15(5):861-71. PubMed ID: 10536167
[TBL] [Abstract][Full Text] [Related]
20. Differential GADD45, p21CIP1/WAF1, MCL-1 and topoisomerase II gene induction and secondary DNA fragmentation after camptothecin-induced DNA damage in two mutant p53 human colon cancer cell lines.
Goldwasser F; Bae I; Fornace AJ; Pommier Y
Oncol Res; 1996; 8(7-8):317-23. PubMed ID: 8938795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
